 
Save the Date for ASV 2027!
|
 |
July 19 - 22, 2027 Madison, Wisconsin
Hosted By: The University of Wisconsin-Madison
Venu: Monona Terrace Convention Center
1 John Nolen Dr.
|
| |
|
|
|
|
|
The American Society for Virology (ASV) invites you to join us for the 46th Annual Meeting, taking place July 19-22, 2027, in Madison, Wisconsin. Hosted by the University of Wisconsin-Madison, the meeting will bring together 1,400-1,800 scientists from around the world for five days of groundbreaking science, collaboration, networking, and professional development.
ASV's Annual Meeting is among the largest and most influential virology conferences in the world. The scientific program features more than 1,000 participant-submitted abstracts, internationally recognized invited speakers, State-of-the-Art lectures, poster sessions, satellite meetings, workshops, and opportunities for discussion across every area of virology- from basic research to vaccines, antiviral therapeutics, ecology, and clinical science.
Held at the iconic Monona Terrace Convention Center in the heart of downtown Madison, attendees will enjoy an inspiring lakefront venue just steps from the Wisconsin State Capitol and a short walk from the University of Wisconsin-Madison campus. Whether you are presenting your latest research, expanding your professional network, or attending for the first time, the ASV Annual Meeting offers an exceptional opportunity to connect with the global virology community.
|
| |
 |
|
|
 |
|
 |
| Nathan Sherer, Ph.D. |
|
Kristen Bernard, Ph.D. |
|
Paul Friesen,Ph.D. |
|
University of Wisconsin-Madison
|
|
University of Wisconsin-Madison
|
|
University of Wisconsin-Madison
|
| Nathan Sherer is a molecular virologist and Professor at Oncology and Molecular Virology at the University of Wisconsin-Madison. He is a faculty member in the McArdle Laboratory for Cancer Research and Institute for Molecular Virology (IMV) and currently serves as Director of the IMV and as Director of the UW-Madison Molecular and Cellular Pharmacology (MCP) Graduate Program. He did PhD training at Yale University in Microbiology and postdoctoral training at King’s College London as an EMBO Long Term Fellow. His research combines live cell imaging with biochemical approaches to study virus-host interactions for the human immunodeficiency virus type 1 (HIV-1) that causes AIDS, hepatitis B virus (HBV) that causes liver disease and hepatocellular carcinoma, and high-risk human papillomaviruses (HPVs) that cause epithelial cancers. |
|
Kristen Bernard is a professor emerit, who studied viral pathogenesis of zoonotic viruses. Her favorite viruses are mosquito-borne viruses. Her first ASV conference was at Colorado State University as a graduate student in 1991 when she fell in love with ASV and has been a member ever since. She has served as ASV President, Veterinary Virology Councilor, and on various ASV committees, including co-host of three conferences at UW-Madison. She is excited about helping to host again in 2027!
Website
|
|
Paul Friesen, PhD, is a leading molecular virologist whose research focuses on the molecular biology of eukaryotic DNA viruses, particularly baculoviruses, and the regulation of viral gene expression. His laboratory investigates how these viruses replicate, interact with host cells, and suppress apoptosis (programmed cell death), providing fundamental insights into virus-host interactions and the mechanisms that govern cellular processes. Through advanced molecular virology techniques, his work has expanded our understanding of viral biology and informed potential therapeutic strategies for diseases involving dysregulated apoptosis.
Website
|
Website
LinkedIn |
|
|
|
|
|
